(Hypertension. 1999;33:124-129.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology, University of Minnesota-Duluth, School of Medicine, Duluth, Minn.
Correspondence to Dr George J. Trachte, Department of Pharmacology, University of Minnesota-Duluth, School of Medicine, 10 University Dr, Duluth, MN 55812. E-mail gtracht1{at}d.umn.edu
AbstractNatriuretic
peptides suppress adrenergic neurotransmission by a mechanism sensitive
to pertussis toxin, suggesting that GTP-binding proteins are involved
in the response. The major GTP-binding proteins present in the
pheochromocytoma (PC12) cells used in this report are Go
and Gi
2. We tested the hypothesis that the
more abundant GTP-binding protein, Go
, mediates
natriuretic peptide effects in PC12 cells by selectively
ablating Go
from the cells with antisense
oligodeoxynucleotides. The results indicate that a
selective ablation of Go
with this technique eliminated
C-type natriuretic peptide (CNP) effects and suppressed
dopamine efflux evoked by a depolarizing stimulus. However, the
activation of guanylyl cyclase (GC) by CNP was sustained after the
Go
ablation. Further,
N
-nitro-L-arginine methyl
ester suppressed evoked dopamine efflux equally in the presence and
absence of Go
. These results suggest that CNP attenuates
evoked catecholamine efflux from PC12 cells by a mechanism
requiring Go
but independent of GC activation.
Key Words: neurotransmission GTP-binding proteins oligodeoxynucleotides, antisense pheochromocytoma cells guanylyl cyclase
This article has been cited by other articles:
![]() |
T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-l. He, D.-c. Chow, M. M. Martick, and K. Christopher Garcia Allosteric Activation of a Spring-Loaded Natriuretic Peptide Receptor Dimer by Hormone Science, August 31, 2001; 293(5535): 1657 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Borges, S. Sanchez de Villarroel, N. J. Winand, I. Lippo de Becemberg, M. J. Alfonzo, and R. Gonzalez de Alfonzo Molecular and Biochemical Characterization of a CNP-Sensitive Guanylyl Cyclase in Bovine Tracheal Smooth Muscle Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 98 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.R Kalra, S.D Anker, A.D Struthers, and A.J.S Coats The role of C-type natriuretic peptide in cardiovascular medicine Eur. Heart J., June 2, 2001; 22(12): 997 - 1007. [PDF] |
||||
![]() |
K. A. Lucas, G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik, and S. A. Waldman Guanylyl Cyclases and Signaling by Cyclic GMP Pharmacol. Rev., September 1, 2000; 52(3): 375 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Trachte Depletion of Natriuretic Peptide C Receptors Eliminates Inhibitory Effects of C-Type Natriuretic Peptide on Evoked Neurotransmitter Efflux J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 210 - 215. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |